Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simcha Jong

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|September 22, 2011
Commercializing a disruptive technologySimcha Jong
Nature Biotechnology|March 12, 2009
When times get toughSimcha Jong
Blockchain in Healthcare Today|February 2, 2026
Use of Blockchain Technology to Accelerate Digital Health Transformation ProgramsRegien Sumo, Simcha Jong
Humanities & Social Sciences Communications|June 11, 2026
When genomics meets geopoliticsWeijia Ding, Simcha Jong
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 4, 2026
Navigating Legitimacy in the Development of Obstructive Sleep Apnea Diagnostics: A Qualitative StudyTaru Kesävuori, Tero Montonen, Päivi Eriksson, et al.
Regenerative Medicine|March 17, 2016
Process change evaluation framework for allogeneic cell therapies: impact on drug development and commercializationSally Hassan, Hsini Huang, Kim Warren, et al.
Scientific Reports|March 14, 2018
Author Correction: The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparisonRo-Ting Lin, Cheng-Kuan Lin, David C Christiani, et al.
Scientific Reports|March 11, 2017
The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparisonRo-Ting Lin, Cheng-Kuan Lin, David C Christiani, et al.
BMC Gastroenterology|July 13, 2019
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseAnkur Srivastava, Simcha Jong, Anna Gola, et al.
Nature Biotechnology|March 10, 2015
Keys to the kingdomSybil C K Wong, Laura S Sasportas, Katie Richardson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|September 22, 2011
Commercializing a disruptive technologySimcha Jong
Nature Biotechnology|March 12, 2009
When times get toughSimcha Jong
Blockchain in Healthcare Today|February 2, 2026
Use of Blockchain Technology to Accelerate Digital Health Transformation ProgramsRegien Sumo, Simcha Jong
Humanities & Social Sciences Communications|June 11, 2026
When genomics meets geopoliticsWeijia Ding, Simcha Jong
Inquiry : a Journal of Medical Care Organization, Provision and Financing|May 4, 2026
Navigating Legitimacy in the Development of Obstructive Sleep Apnea Diagnostics: A Qualitative StudyTaru Kesävuori, Tero Montonen, Päivi Eriksson, et al.
Regenerative Medicine|March 17, 2016
Process change evaluation framework for allogeneic cell therapies: impact on drug development and commercializationSally Hassan, Hsini Huang, Kim Warren, et al.
Scientific Reports|March 14, 2018
Author Correction: The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparisonRo-Ting Lin, Cheng-Kuan Lin, David C Christiani, et al.
Scientific Reports|March 11, 2017
The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparisonRo-Ting Lin, Cheng-Kuan Lin, David C Christiani, et al.
BMC Gastroenterology|July 13, 2019
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseAnkur Srivastava, Simcha Jong, Anna Gola, et al.
Nature Biotechnology|March 10, 2015
Keys to the kingdomSybil C K Wong, Laura S Sasportas, Katie Richardson, et al.
Pageof 2